Sort by
Refine Your Search
-
degree (PhD or equivalent) in computer science, data science, statistics, bioinformatics, or a related discipline A strong publication record in machine learning, computer science, bioinformatics
-
publication funding are included, and the role offers strong support for career development, including pathways to ERC Starting Grant applications. Essential Selection Criteria You must have: A PhD (or
-
technicians in designing and conducting molecular biology experiments. Writing own grant applications Skills, expertise and/or qualifications A PhD degree in any relevant field of life sciences Successfully
-
expected to: advance the research project together with the project team and conduct doctoral studies and research work leading to a completed PhD thesis within 4 years. Your work may also include teaching
-
research / molecular biology. The proposed project is intended for an MSc-level person who wishes to acquire PhD degree. PhD Trainees in my laboratory typically graduate within 3-4 years with competitive
-
findings to the rest of the team. We help each other to succeed in making exciting new scientific discoveries. You would be expected to complete a PhD thesis within four years. Your network and team As the
-
within a multidisciplinary research environment spanning two Nordic countries, with active groups in Helsinki and Oslo. The position is open to applicants with a PhD degree in computational biology
-
the benchmarking of continuum modeling code together with GTK. Take part in dissemination, outreach, and teaching activities. Profile of the candidate PhD in relevant field (Physics, Chemistry, Geology, Fluid
-
://www.helsinki.fi/hilife/bi . Project Summary We are seeking a PhD student to join the project "Mutation clusters and origin of regulatory RNA genes" funded by the Jane and Aatos Erkko Foundation and led by Dr Heli
-
experience in wet-lab and computational techniques. This position is intended for an MSc-level graduate planning to pursue a PhD degree. In this project, we aim to profile AML cancer cells treated with drug